Key result
Cryo-EM structures of human NaV1.6 reveal the molecular mechanism of Na+ selectivity and show that 4,9-anhydro-tetrodotoxin occupies the Na+ binding sites to completely block the channel.
Why the study?
NaV1.6 dysfunction is linked to epileptic encephalopathy, intellectual disability, and movement disorders, but the structural basis of its ion selectivity and blocker inhibition remained unclear.
This is the authors' abstract. We don't add key points for this paper.
The sodium channel Na V 1.6 is widely expressed in neurons of the central and peripheral nervous systems, which plays a critical role in regulating neuronal excitability. Dysfunction of Na V 1.6 has been linked to epileptic encephalopathy, intellectual disability and movement disorders. Here we present cryo-EM structures of human Na V 1.6/β1/β2 alone and complexed with a guanidinium neurotoxin 4,9-anhydro-tetrodotoxin (4,9-ah-TTX), revealing molecular mechanism of Na V 1.6 inhibition by the blocker. In the apo-form structure, two potential Na + binding sites were revealed in the selectivity filter, suggesting a possible mechanism for Na + selectivity and conductance. In the 4,9-ah-TTX-bound structure, 4,9-ah-TTX binds to a pocket similar to the tetrodotoxin (TTX) binding site, which occupies the Na + binding sites and completely blocks the channel. Molecular dynamics simulation results show that subtle conformational differences in the selectivity filter affect the affinity of TTX analogues. Taken together, our results provide important insights into Na V 1.6 structure, ion conductance, and inhibition.
Answers are grounded in this paper and cite their sources.
The cryo-EM structure of human NaV1.6 provides molecular insights into sodium channel selectivity and its specific inhibition by 4,9-anhydro-tetrodotoxin, which may guide future drug design for neurological disorders.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied NaV1.6 channel structure and function. 4,9-anhydro-tetrodotoxin (4,9-ah-TTX) vs. Tetrodotoxin (TTX) was evaluated on IC50 for NaV1.6 inhibition. Cryo-EM structures of human NaV1.6 reveal the molecular mechanism of Na+ selectivity and show that 4,9-anhydro-tetrodotoxin occupies the Na+ binding sites to completely block the channel.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: